Impaired high-density lipoprotein anti-oxidant capacity in human abdominal aortic aneurysm.

AIMS Abdominal aortic aneurysm (AAA) is a particular form of atherothrombotic disease characterized by the dilation of the aortic wall and the presence of an intraluminal thrombus (ILT). The objective of the present study was to evaluate the pro-oxidant properties of the ILT and to characterize the anti-oxidant capacity of high-density lipoproteins (HDLs). METHODS AND RESULTS Our results show that ILT, adventitia, and plasma from AAA patients contained high concentrations of lipid and protein oxidation products. Mediators produced within or released by the thrombus and the adventitia were shown to induce reactive oxygen species (ROS) production by cultured aortic smooth muscle cells (AoSMCs) and to trigger the onset of apoptosis (an increase in mitochondrial membrane potential). Iron chelation limited these effects. Both concentration and functionality of HDLs were altered in AAA patients. Plasma levels of Apo A-I were lower, and small HDL subclasses were decreased in AAA patients. Circulating HDLs in AAA patients displayed an impaired capacity to inhibit copper-induced low-density lipoprotein oxidation and AoSMC ROS production. Western blot analyses of HDLs demonstrated that myeloperoxidase is associated with HDL particles in AAA patients. CONCLUSION ILT and adventitia are a source of pro-oxidant products, in particular haemoglobin, which may impact on the wall stability/rupture in AAA. In addition, HDLs from AAA patients exhibit an impaired anti-oxidant activity. In this context, restoring HDL functionality may represent a new therapeutic option in AAA.

[1]  J. Egido,et al.  Statin use in aortic aneurismal disease to prevent progression and cardiovascular events: review of experimental and clinical data C. , 2013, Current vascular pharmacology.

[2]  F. Moll,et al.  Intraluminal abdominal aortic aneurysm thrombus is associated with disruption of wall integrity. , 2013, Journal of vascular surgery.

[3]  B. Baxter,et al.  Elevation of Plasma High-Density Lipoproteins Inhibits Development of Experimental Abdominal Aortic Aneurysms , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[4]  J. Golledge,et al.  Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. , 2012, The American journal of pathology.

[5]  J. Wojta,et al.  Simvastatin decreases free radicals formation in the human abdominal aortic aneurysm wall via NF-κB. , 2012, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[6]  E. Eren,et al.  High Density Lipoprotein and it’s Dysfunction , 2012, The open biochemistry journal.

[7]  J. Michel,et al.  Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: Detoxifying mechanisms and potential therapeutic options , 2012, Thrombosis and Haemostasis.

[8]  Y. Okita,et al.  Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats. , 2012, Journal of vascular surgery.

[9]  S. Pennathur,et al.  Myeloperoxidase Targets Apolipoprotein A-I, the Major High Density Lipoprotein Protein, for Site-Specific Oxidation in Human Atherosclerotic Lesions* , 2012, The Journal of Biological Chemistry.

[10]  J. Michel,et al.  Proteomic Analysis of Polymorphonuclear Neutrophils Identifies Catalase as a Novel Biomarker of Abdominal Aortic Aneurysm: Potential Implication of Oxidative Stress in Abdominal Aortic Aneurysm Progression , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[11]  A. Kontush,et al.  Biological activities of HDL subpopulations and their relevance to cardiovascular disease. , 2011, Trends in molecular medicine.

[12]  M. Haas,et al.  Inflammation, high-density lipoprotein and cardiovascular dysfunction , 2011, Current opinion in infectious diseases.

[13]  Naihao Lu,et al.  Effects of glutathione, Trolox and desferrioxamine on hemoglobin-induced protein oxidative damage: anti-oxidant or pro-oxidant? , 2011, European journal of pharmacology.

[14]  J. Michel,et al.  Identification of Peroxiredoxin-1 as a Novel Biomarker of Abdominal Aortic Aneurysm , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Robert J. Hinchliffe,et al.  Pathophysiology and epidemiology of abdominal aortic aneurysms , 2011, Nature Reviews Cardiology.

[16]  Jean-Baptiste Michel,et al.  Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans , 2010, Cardiovascular research.

[17]  Abigail S Haka,et al.  Mechanism of ceroid formation in atherosclerotic plaque: in situ studies using a combination of Raman and fluorescence spectroscopy. , 2011, Journal of biomedical optics.

[18]  H. Takagi,et al.  Serum high-density and low-density lipoprotein cholesterol is associated with abdominal aortic aneurysm presence: a systematic review and meta-analysis. , 2010, International angiology : a journal of the International Union of Angiology.

[19]  E. Nilsson,et al.  HDL in humans with cardiovascular disease exhibits a proteomic signature. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[20]  K. Jamrozik,et al.  Association between serum lipoproteins and abdominal aortic aneurysm. , 2010, The American journal of cardiology.

[21]  N. Fukagawa,et al.  Age-related changes in redox signaling and VSMC function. , 2010, Antioxidants & redox signaling.

[22]  Jean-BaptisteMichel,et al.  Hemorphin 7 Reflects Hemoglobin Proteolysis in Abdominal Aortic Aneurysm , 2010 .

[23]  A. Burlingame,et al.  HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  K. Rye,et al.  High-density lipoproteins, inflammation and oxidative stress. , 2009, Clinical science.

[25]  A. Nègre-Salvayre,et al.  Caveolin-1 sensitizes vascular smooth muscle cells to mildly oxidized LDL-induced apoptosis. , 2008, Biochemical and biophysical research communications.

[26]  A. Nègre-Salvayre,et al.  Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity. , 2008, Atherosclerosis.

[27]  E. Schaefer,et al.  Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction. , 2007, The American journal of cardiology.

[28]  R. Keep,et al.  A New Hippocampal Model for Examining Intracerebral Hemorrhage-Related Neuronal Death: Effects of Deferoxamine on Hemoglobin-Induced Neuronal Death , 2007, Stroke.

[29]  Jean-Baptiste Michel,et al.  Topological Determinants and Consequences of Adventitial Responses to Arterial Wall Injury , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[30]  N. Weintraub,et al.  Role of Oxidative Stress in the Pathogenesis of Abdominal Aortic Aneurysms , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[31]  B. Vogt,et al.  Rethinking the Triggering Inflammatory Processes of Chronic Periaortitis , 2006, Nephron Experimental Nephrology.

[32]  A. Kontush,et al.  Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis , 2006, Pharmacological Reviews.

[33]  N. Brot,et al.  Myeloperoxidase Impairs ABCA1-dependent Cholesterol Efflux through Methionine Oxidation and Site-specific Tyrosine Chlorination of Apolipoprotein A-I* , 2006, Journal of Biological Chemistry.

[34]  Bin Lou,et al.  Neutrophils activation can be diminished by apolipoprotein A-I. , 2005, Life sciences.

[35]  Z. Lijun,et al.  Role of macrophage and smooth muscle cell apoptosis in association with oxidized low-density lipoprotein in the atherosclerotic development , 2005, Modern Pathology.

[36]  Michael Kinter,et al.  Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. , 2004, The Journal of clinical investigation.

[37]  J. Michel,et al.  Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. , 2004, The American journal of pathology.

[38]  K. Uchida,et al.  Rapid formation of 4-hydroxy-2-nonenal, malondialdehyde, and phosphatidylcholine aldehyde from phospholipid hydroperoxide by hemoproteins. , 2004, Free radical biology & medicine.

[39]  J. Graessler,et al.  The protective effects of HDL and its constitutents against neutrophil respiratory burst activation by hypochlorite-oxidized LDL , 2004, Molecular and Cellular Biochemistry.

[40]  J. Heinecke,et al.  Lysine Residues Direct the Chlorination of Tyrosines in YXXK Motifs of Apolipoprotein A-I When Hypochlorous Acid Oxidizes High Density Lipoprotein* , 2004, Journal of Biological Chemistry.

[41]  R. Dietz,et al.  Intracellular superoxide induces apoptosis in VSMCs: Role of mitochondrial membrane potential, cytochrome c and caspases , 2002, Apoptosis.

[42]  Per Eriksson,et al.  Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall. , 2003, Journal of vascular surgery.

[43]  A. Kontush,et al.  Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[44]  Gerard E. Dallal,et al.  Change in &agr;1 HDL Concentration Predicts Progression in Coronary Artery Stenosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[45]  J. Michel,et al.  Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. , 2002, The American journal of pathology.

[46]  L. Oberley,et al.  Oxidative Stress in Human Abdominal Aortic Aneurysms: A Potential Mediator of Aneurysmal Remodeling , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[47]  M. Dubick,et al.  Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[48]  P. Jungers,et al.  Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. , 1998, Journal of immunology.

[49]  Tzong-Shyuan Lee,et al.  Colocalization of iron and ceroid in human atherosclerotic lesions. , 1998, Atherosclerosis.

[50]  A. Nègre-Salvayre,et al.  Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway. Prevention by aurintricarboxylic acid. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[51]  J. Pincemail,et al.  Decrease of Plasma Vitamin E (α‐Tocopherol) Levels in Patients with Abdominal Aortic Aneurysm , 1996, Annals of the New York Academy of Sciences.

[52]  K. Yagi,et al.  A simple fluorometric assay for lipoperoxide in blood plasma. , 1976, Biochemical medicine.

[53]  J. Guichard,et al.  Fine structural and cytochemical identification of microperoxisomes in developing human erythrocytic cells. , 1975, The American journal of pathology.